Abstract:The gene editing technology enables cutting or/and inserting the target gene precisely. The CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated protein 9) system relies on two major elements, a guide RNA (gRNA) that recognizes a specific DNA sequence, and a nuclease Cas9 that cuts the target DNA and creates double-strand breaks (DSBs). Among a few gene-editing technologies available, CRISPR/Cas9 system has showed tremendous advantages over the others, mainly due to high efficiency of Cas9 and simple design of gRNA. As a versatile and powerful tool for genome engineering, the CRISPR/Cas9 technology has been used to generate genetically modified mice with unprecedented simplicity and speed, simply by timed delivery of Cas9/gRNA ribonucleoproteins (RNPs) into pronuclear-stage zygotes. The modified protocol introduces Cas9 protein instead of Cas9 mRNA by rapid electroporation, which enables the gene editing occurring before the first replication of the mouse genome, thus generating non-mosaic mutant embryos. Furthermore, it could be used to produce multiple gene mutations in a single mouse by co-delivering several gRNAs targeted to different genes. Herein, we summarize current applications of CRISPR/Cas9 technology in the field of neuroscience, and aim to provide concise information and perspectives for better utilizing this technology. In brain research, the CRISPR/Cas9 system can be applied either at the one-cell stage of the fertilized eggs in the form of Cas9/gRNA ribonucleoproteins, or at the stage of embryos or adults in the form of plasmid DNA or the viral vectors (commonly AAV variants) respectively. To deliver the system specifically into the developmental or adult brain, in utero electroporation, or stereotaxic injection is commonly employed. Several reports show that AAV-assisted Cas9/gRNA system could achieve a satisfied efficiency for genome editing in the adult mouse brain, but results vary depending on Cas9 activity, gRNA design, detection methods, and the condition of endogenous DNA repair mechanisms. Remarkable efforts have also been made to enhance the incidence of homology-directed repair for precise gene modifications. Regarding therapeutic genome editing, a couple of recent in vivo studies demonstrate that CRISPR/Cas9 system could contract or remove disease-causing alleles in animal models of certain hereditary diseases such as retinitis pigmentosa and Huntington′s disease, raising hope for translating therapeutic genome editing to clinical patients. In addition, we discuss major challenges and critical improvements for this technology, including a few modifications for promoting precise editing in non-dividing cells in the case of adult brain. In the future, application of CRISPR/Cas9 technology would be enhanced greatly in neuroscience by developing cell type-specific, timed delivery system in vivo and by combining with other powerful techniques for dissecting brain neural circuits in health and disease.

CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders

Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders

Recent Therapeutic Gene Editing Applications to Genetic Disorders

Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders

Genome Editing in iPSC-Based Neural Systems: From Disease Models to Future Therapeutic Strategies

Building CRISPR Gene Therapies for the Central Nervous System

Vector enabled CRISPR gene editing – A revolutionary strategy for targeting the diversity of brain pathologies

Application of novel CRISPR tools in brain therapy

Nanotechnology and CRISPR/Cas-Mediated Gene Therapy Strategies: Potential Role for Treating Genetic Disorders

Exploring the Potential and Challenges of CRISPR Delivery and Therapeutics for Genetic Disease Treatment

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

CRISPR/Cas9 genome editing clinical trials for neurodevelopmental disorders

CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments

CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future

Development and application of CRISPR/Cas9 technologies in genomic editing.

Strategy for Applying CRISPR/Cas9 Gene Editing Technology in Neuroscience

CRISPR/Cas9-mediated genome editing: from basic research to gene therapy

Basic Principles and Clinical Applications of CRISPR-Based Genome Editing

CRISPR-engineered genome editing for the next generation neurological disease modeling

Rare immune diseases paving the road for genome editing-based precision medicine

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing